Estradiol GI side effects on day 10: what the science says

What did @noneyabusin3zz actually say?

Not much, honestly, and that's not a criticism. This is a low-stakes check-in video. The creator says they're on day 10 of taking estradiol, they have a stomach ache that started the night before, and they suspect it might be related to "the prep" they're taking alongside their estrogen. They skipped Pilates because of the discomfort and are heading to bed. No dosage claims, no miracle promises, no medical advice to others.

The word "extra dial" in the transcript is a phonetic transcription error from auto-captioning. They clearly mean estradiol, the primary estrogen used in feminizing hormone therapy. Worth noting because these transcription errors sometimes get screenshotted and misread out of context.

Does the science back this up?

The claim that GI discomfort can occur when starting estradiol, especially oral forms, is well-supported. This isn't controversial territory.

Oral estradiol is metabolized through the liver via first-pass metabolism, which can irritate the GI tract in some people during the early weeks of use. A 2019 review by Streed et al. in the Annals of Internal Medicine noted that GI side effects are among the more commonly reported early complaints with oral hormone therapy in transgender women, though they tend to be mild and transient.

The creator also mentions taking something alongside the estradiol, referring to it as "prep." If they mean PrEP (pre-exposure prophylaxis for HIV, typically tenofovir-based), that's a relevant detail. Tenofovir disoproxil fumarate, a common PrEP component, has documented GI side effects including nausea and abdominal discomfort, particularly in the first few weeks. A 2012 study by Grant et al. in the New England Journal of Medicine flagged nausea as the most frequently reported early side effect in PrEP users. The combination of two medications each capable of causing GI upset on their own makes the stomach ache entirely plausible.

What did they get wrong (or right)?

They got the self-awareness right. Attributing the stomach pain to a medication rather than panicking or ignoring it is reasonable health behavior. They're not diagnosing themselves or telling anyone else what to do.

What's missing, not wrong exactly, is any mention of checking in with a provider. Ten days into a new hormone regimen with GI symptoms that are bad enough to cancel exercise is worth a message to whoever is prescribing. Not because this is alarming, most early GI symptoms from estradiol resolve on their own, but because persistent pain can occasionally signal something unrelated that gets written off as a medication side effect.

The video is also categorized here under TRT (testosterone replacement therapy), which is incorrect. Estradiol is not testosterone. Feminizing hormone therapy and TRT are distinct clinical categories with different goals, monitoring protocols, and risk profiles. That's a platform categorization issue, not the creator's error, but it matters for anyone using these tags to find relevant health information.

What should you actually know?

GI discomfort in the first weeks of oral estradiol is common and usually temporary. If it persists beyond a few weeks or worsens significantly, that's a conversation for whoever manages your hormones, not something to push through silently.

Route of administration matters here. Transdermal estradiol (patches, gels) bypasses first-pass liver metabolism entirely, which tends to reduce GI side effects. Some people switch routes specifically for this reason. That's a clinical decision, not a DIY one, but it's worth knowing the option exists if oral estradiol keeps causing problems.

If the creator is indeed taking PrEP alongside estradiol, some formulations interact mildly with hormone levels, though current evidence does not suggest tenofovir-based PrEP significantly disrupts estradiol pharmacokinetics at standard doses. A 2021 paper by Shieh et al. in the Journal of Acquired Immune Deficiency Syndromes examined this specifically in transgender women and found no clinically meaningful estradiol suppression from PrEP use, though they noted the research base remains thin.

Anyone starting a new hormone regimen should have baseline labs and follow-up monitoring scheduled. This is standard of care, not optional, and a regulated telehealth platform should be building this in from day one.